Skip to main content
Clinical Trials/NCT02026531
NCT02026531
Completed
Phase 1

Novel MRI Techniques in the Evaluation of Pulmonary Vascular Disease

Sheffield Teaching Hospitals NHS Foundation Trust1 site in 1 country9 target enrollmentNovember 2010

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Pulmonary Hypertension
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Enrollment
9
Locations
1
Primary Endpoint
pulmonary artery diameter (mm)
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The diagnosis of a patient with pulmonary hypertension (PH) requires many investigations. At present cardiac catheterisation is the cornerstone investigation in these patients where it is used to establish disease severity and estimate prognosis. It is an invasive procedure which is expensive and not without risk to the patient. Despite the multitude of tests performed, identifying those patients with PH who have a poor diagnosis can be difficult. The aim of this study is to improve the assessment of patients with PH using novel magnetic resonance techniques.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
September 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All cases referred to the clinic for assessment for possible pulmonary hypertension.

Exclusion Criteria

  • patients with a cardiac pacemaker or retained temporary pacing wire
  • patients with aneurysm clip
  • non MRI compatible heart valve prosthesis
  • intra orbital metalic foreign body
  • pregnancy
  • metal prosthesis/spinal rods
  • retained shrapnel
  • cochlear implants/bladder stimulator

Outcomes

Primary Outcomes

pulmonary artery diameter (mm)

Time Frame: up to 3 months

Three-dimensional MRI imaging will be used to acquire cardiac dimensions and anatomical ventilation distribution as well as regional partial pressures of oxygen in the lungs.

Study Sites (1)

Loading locations...

Similar Trials